Characteristics | Â | n (%) |
---|---|---|
Age (year) | Median 65 (range, 39–81) | |
Gender | Â | Â |
 | Male | 17(54.8) |
 | Female | 14(45.2) |
Complicated with chronic diseases | 15(48.4) | |
Pathological differentiation | Â | Â |
 | well differentiation | 28(90.3) |
 | poor differentiation | 3(9.7) |
Tumor position | Â | Â |
 | proximal segment | 5(16.1) |
 | middle and distal segment | 26(83.9) |
Surgical margrin status | Â | Â |
 | R0 | 25(80.6) |
 | R1 | 6(19.4) |
pT classification | ||
 | T1 | 8(25.8) |
 | T2 | 12(38.7) |
 | T3 | 9(29.0) |
 | T4 | 2(6.5) |
pTNM staging | Â | Â |
 | I | 8(25.8) |
 | II | 12(38.7) |
 | III | 9(29.0) |
 | IV | 2(6.5) |
Risk stratification | Â | Â |
 | Low-risk | 20(64.5) |
 | High-risk | 11(35.5) |
Postoperative chemotherapy | Â | Â |
 | Yes | 4(12.9) |
 | No | 27(87.1) |
Post-radiotherapy treatment | Â | Â |
 | Yes | 5(16.1) |
 | No | 26(83.9) |
Duration of radiotherapy | Median 36 days(range 32-62Â days) |